I'm a Pathologist. Every Weight-Loss Peptide Stack, Graded.

Dr. Amin Hedayat, MD

Dr. Amin Hedayat, MD

48,242 views

Are peptides and stacks for weight loss and longevity safe? A clinical pathologist audits Ozempic, BPC-157 side effects, Retatrutide results, and the grey market danger. This complete guide also breaks down the real science behind semaglutide (Wegovy), Tirzepatide (Mounjaro, Zepbound), GHK-Cu, TB-500, Tesamorelin, HGH, Russian Bioregulators such as Pinealon.

📥 Download The Vial Audit (Free Guide): https://draminhedayat.com/vial_audit

🌐 Join the Waitlist: https://www.getuninflamed.com

⏱️ CHAPTERS:
00:00 - Introduction & The Grey Market Danger
00:01:29 - The Three Colors of Peptides (Safe vs. Unsafe)
00:07:06 - GLP-1 Impact: Ozempic & Retatrutide Results
00:14:25 - BPC-157 Side Effects & Healing Claims
00:19:28 - Russian Bioregulators Explained
00:20:50 - Thymus Peptides & Thymosin Alpha-1
00:26:21 - The ER Mistake: Risks, Vials & Sourcing
00:30:08 - Pathologist's Final Verdict on Peptides

📚 CLINICAL SOURCES & DATA:
GLP-1 weight-loss trials
STEP 1 (semaglutide). Wilding et al., NEJM 2021. https://doi.org/10.1056/NEJMoa2032183
SURMOUNT-1 (tirzepatide). Jastreboff et al., NEJM 2022. https://doi.org/10.1056/NEJMoa2206038
SURMOUNT-5 (tirzepatide vs semaglutide). Aronne et al., NEJM 2025. https://doi.org/10.1056/NEJMoa2416394
Retatrutide phase 2. Jastreboff et al., NEJM 2023. https://doi.org/10.1056/NEJMoa2301972
Retatrutide phase 3 (investigational, TRIUMPH-1, May 2026). https://investor.lilly.com/news-relea...
Heart and brain
SELECT (cardiovascular outcomes). Lincoff et al., NEJM 2023. https://doi.org/10.1056/NEJMoa2307563
Alcohol use disorder. Hendershot et al., JAMA Psychiatry 2025. https://doi.org/10.1001/jamapsychiatr...
EVOKE and EVOKE+ (Alzheimer's, negative result). Lancet 2026. https://www.thelancet.com/journals/la...
Muscle and lean mass
Neeland, Linge, Birkenfeld, Diabetes Obes Metab 2024. https://doi.org/10.1111/dom.15728
Growth hormone
Tesamorelin (FDA-approved). Falutz et al., NEJM 2007. https://doi.org/10.1056/NEJMoa072375
BPC-157
Systematic review (544 papers, 1 human study). Vasireddi et al., HSS Journal 2025. https://doi.org/10.1177/1556331625135...
FDA compounding review docket (503A). https://www.regulations.gov/docket/FD...
WADA prohibited list (banned since 2022). https://www.wada-ama.org/en/news/wada...
Thymus
Thymus removal in adults (observational). Kooshesh et al., NEJM 2023. https://doi.org/10.1056/NEJMoa2302892
TRIIM thymus pilot (9 people). Fahy et al., Aging Cell 2019. https://doi.org/10.1111/acel.13028
GHK-copper
Pickart & Margolina, Int J Mol Sci 2018. https://doi.org/10.3390/ijms19071987
Supply chain and safety
FDA alert, compounded semaglutide dosing errors (July 2024). https://www.fda.gov/drugs/human-drug-...

#Peptides #Ozempic #BPC157 #Retatrutide #metabolichealth

📺 WATCH NEXT:
How To Stop The Rebound With Ozempic & Mounjaro
👉 How To Stop The Rebound With Ozempic & Mou...

How To Boost GLP-1 Naturally (No Injections)
👉 I’m a Pathologist: Do This To Boost GLP-1 ...

Retatrutide is NOT Ozempic. It's Biological Overdrive.
👉 I’m a Pathologist. Retatrutide is NOT Ozem...

Ozempic & Mounjaro Aren't Actually Weight Loss Drugs
👉 I'm a Pathologist. Ozempic & Mounjaro Aren...

The "Biological Cost" of Ozempic and Mounjaro
👉 I’m a Pathologist: The "Biological Cost" o...


Disclaimer: The information provided in this video is for educational and informational purposes and does not establish a doctor-patient relationship. Dr. Hedayat is a triple board certified physician, but he is not your physician. Always consult with a licensed, qualified healthcare professional before starting any new treatment, peptide, diet, or medication.